Pathogenetic features of endothelial dysfunction at respiratory-cardiac comorbidity

Pathogenetic features of endothelial dysfunction at respiratory-cardiac comorbidity

A correlation analysis to identify the relationship between markers of endothelial dysfunction (coefficient of endothelial function - EFC, type C natriuretic peptide, endothelin-1) and indicators reflecting the activity of inflammation (C - reactive protein, fractalkine) in patients with chronic obs...

Full description

Bibliographic Details
Main Authors:	A. Kh. Akhmineeva, O. S. Polunina, I. V. Sevostyanova, L. P. Voronina
Format:	Article
Language:	Russian
Published:	Ministry of Healthcare of the Russian Federation. “Kuban State Medical University” 2014-08-01
Series:	Кубанский научный медицинский вестник
Subjects:	хроническая обструктивная болезнь легких бронхиальная астма ишемическая болезнь сердца артериальная гипертензия эндотелиальная дисфункция системное воспаление chronic obstructive pulmonary disease bronchial asthma coronary heart disease arterial hypertension endothelial dysfunction systemic inflammation
Online Access:	https://ksma.elpub.ru/jour/article/view/168

Similar Items

THE RELATIONSHIP BETWEEN THE LEVEL OF SUPEROXIDDISMUTASE AND THE COEFFICIENT OF ENDOTHELIAL FUNCTION AT RESPIRATORY-CARDIAC COMORBIDITY
by: O. S. Polunina, et al.
Published: (2014-02-01)

The level of c-type natriuretic peptide in patients with respiratory cardial comorbidity, depending on genotypes of the gene of endothelial nitric oxide synthase
by: O S Polunina, et al.
Published: (2013-12-01)

Vascular endothelial dysfunction and comorbid conditions in bronchial asthma
by: A. Kh. Akhmineeva, et al.
Published: (2014-04-01)

THE ROLE OF FRACTALKINE AS A MARKER OF THE INFLAMMATORY ACTIVITY AT COMBINED RESPIRATORY CARDIAC PATHOLOGY
by: A. Kh. Akhmineeva, et al.
Published: (2014-02-01)

The influence of catalaza gene polymorphism on the development of cardiovascular pathology in chronic obstructive pulmonary disease
by: T A Uklistaya, et al.
Published: (2012-12-01)

Pharmacoepidemiological treatment analysis of the chronic obstructive pulmonary disease and bronchial asthma at the inpatients department
by: I V Tarasenko, et al.
Published: (2010-12-01)

FEATURES OF THE SYNTHESIS OF NITRIC OXIDE IN PATIENTS WITH BRONCHIONAL ASTHMA AND CHRONIC OBSTRUCTIVE PULMONARY DISEASE
by: Z. O. Dzuskaeva, et al.
Published: (2015-06-01)

Кардиореспираторные послеоперационные осложнения у пациентов с ишемической болезнью сердца после планового коронарного шунтирования: связь с функцией легких
by: E. V. Bazdyrev, et al.
Published: (2017-07-01)

Osobennosti techeniya serdechno-sosudistykh zabolevaniy i printsipy vybora ratsional'noy antigipertenzivnoy terapii u bol'nykh khronicheskoy obstruktivnoy bolezn'yu legkikh
by: Dmitriy Aleksandrovich Napalkov, et al.
Published: (2013-09-01)

Regional pharmacotherapy features of a bronchial asthma and chronic obstructive pulmonary disease
by: V A Lopukhova, et al.
Published: (2010-12-01)

Circadian blood pressure profile in patients with arterial hypertension and chronic obstructive pulmonary disease
by: T. E. Steshina, et al.
Published: (2005-08-01)

FEATURES OF THE PSYCHOLOGICAL PROFILE OF PATIENTS WITH CHRONIC OBSTRUCTIVE LUNG DISEASE IN THE CONDITIONS OF COMORBIDITY
by: Evgeny Vyacheslavovich Kozlov, et al.
Published: (2019-07-01)

THE EFFECT OF SOCIO-ECONOMIC FACTORS ON THE QUALITY OF LIFE IN PATIENTS WITH CHRONIC OBSTRUCTIVE LUNG DISEASE IN CONDITIONS OF COMORBIDITY
by: Evgeny Vyacheslavovich Kozlov, et al.
Published: (2019-06-01)

Effektivnost' i bezopasnost' primeneniya Betaloka ZOK i Logimaksa u bol'nykh myagkoy arterial'noy gipertenziey v sochetanii s khronicheskoy obstruktivnoy bolezn'yu legkikh
by: I E Chazova, et al.
Published: (2005-03-01)

CHANGES IN THE PARAMETERS OF 24-HOUR BLOOD PRESSURE MONITORING AND ARTERIAL STIFFNESS IN PATIENTS WITH HYPERTENSION AND CHRONIC OBSTRUCTIVE PULMONARY DISEASE TREATED WITH VALSARTAN
by: N. A. Karoli, et al.
Published: (2015-09-01)

SECONDARY PHARMACOLOGICAL PREVENTION OF CARDIOVASCULAR DISEASES: OUR ABILITY IN CLINICAL PRACTICE
by: E. V. Filippov, et al.
Published: (2015-12-01)

The chronic obcructive pulmonary disease in military veterans: problems and perspectives
by: G I Gurko
Published: (2010-12-01)

Changes in functional status and inflammation profile in patients with chronic obstructive pulmonary disease during therapy with tiotropium
by: I. N. Trofimenko, et al.
Published: (2015-12-01)

ANTHROPOMETRIC FEATURES AND COMPONENT STRUCTURE OF BODY MASS IN MEN WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE IN CONDITIONS OF COMORBIDITY
by: Evgeny Vyacheslavovich Kozlov, et al.
Published: (2019-05-01)

FEATURES OF INDICATORS OF DAILY MONITORING OF ARTERIAL PRESSURE IN MEN WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE IN THE CONTEXT OF COMORBIDITY
by: Evgeny Vyacheslavovich Kozlov, et al.
Published: (2019-05-01)

Immunological aspects of the development of hypertension and renal dysfunction in patients with chronic diseases of joints
by: A V Safronenko, et al.
Published: (2012-09-01)

Approaches to the diagnosis, treatment and prevention of exacerbations of chronic obstructive pulmonary disease. According to the materials of the Congress «Chelovek I lekarstvo» and the Summit of pulmonologists-2019
by: Yu. V. Evsyutina
Published: (2019-12-01)

Influence of COPD on the development of renal disease and identification of nature of kidney with specific markers
by: V V Trishina, et al.
Published: (2012-06-01)

ATRIAL FIBRILLATION IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE
by: E. I. Leonova, et al.
Published: (2015-09-01)

Role of copd in the development of kidney pathology
by: V V Trishina, et al.
Published: (2011-06-01)

Prevalence of ischemic heart disease among males with tuberculosis
by: V A Koshechkin, et al.
Published: (2011-09-01)

COMORBIDITY IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE: A ROLE OF CARDIOVASCULAR DISORDERS
by: N. A. Karoli, et al.
Published: (2016-01-01)

«MEMORIES OF FUTURE»: CHANGE IN VERAPAMIL SIGNIFICANCE IN THE TREATMENT OF PATIENTS WITH ISCHEMIC HEART DISEASE AND ARTERIAL HYPERTENSION
by: S. R. Gilyarevskiy
Published: (2015-09-01)

Антибактериальная терапия инфекций дыхательных путей: практические рекомендации
Published: (2016-12-01)

EFFECT OF BRONCHODILATORS ON HEART RATE VARIABILITY IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE
by: H. H. Shugushev, et al.
Published: (2015-12-01)

SYSTEMIC ARTERIAL HYPERTENSION ASSOCIATED WITH CHRONIC OBSTRUCTIVE LUNG DISEASE
by: S. A. Pavlishchuk, et al.
Published: (2014-02-01)

Budesonide in patients with obstructive pulmonary disease
by: N. N. Mescheryakova
Published: (2015-12-01)

Methodological aspects of the study of the pharmaceutical care to patients of chronic obstructive pulmonary disease
by: N O Karabintseva, et al.
Published: (2013-12-01)

КЛИНИЧЕСКОЕ ПРИМЕНЕНИЕ КВАДРОПРИЛА У БОЛЬНЫХ АРТЕРИАЛЬНОЙ ГИПЕРТОНИЕЙ В СОЧЕТАНИИ С ХРОНИЧЕСКОЙ ОБСТРУКТИВНОЙ БОЛЕЗНЬЮ ЛЕГКИХ
Published: (2006-12-01)

ASSESSMENT OF SYSTEMIC INFLAMMATORY REACTION IN ACUTE MYOCARDIAL INFARCTION: STATUS UPDATE ON THE PROBLEM
by: M. A Kachkovsky, et al.
Published: (2015-09-01)

CARDIOPROTECTIVE EFFECT OF PHYSICAL REHABILITATION IN PATIENTS WITH ISCHEMIC-ORIGIN DIASTOLIC DYSFUNCTION AFTER PERCUTANEOUS CORONARY INTERVENTION
by: N. P. Lyamina, et al.
Published: (2015-12-01)

ALGORITHM FOR MANAGEMENT OF HYPERTENSIVE PATIENTS UNDERWENT UROLOGY INTERVENTIONS
by: S. S. Davydova
Published: (2015-09-01)

Effect of selective β-blockers on spirometry in a 4 hour bronchial provocation test in patients with bronchoobstructive pathology
by: K. A. Zykov, et al.
Published: (2014-12-01)

CHANGES OF INTERCELLULAR COOPERATION IN PERIPHERAL BLOOD IN TREATED PATIENTS WITH CARDIOLOGIC DISEASES
by: L. N. Korichkina, et al.
Published: (2016-01-01)

Prognostic role of metabolic risk factors (hyperhomocysteinemia) in the development of chronic heart failure
by: Е. Н. Березикова, et al.
Published: (2015-10-01)